Clinical Trials Browser

Phase 3 × OTHER × Ivabradine × Clear all

NCT04030546 2019-12-18

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Phase 3 Unknown

Heart Failure, Cardiotoxicity